Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo

Cisplatin is a commonly used chemotherapeutic drug for treatment of oral carcinoma, and combinatorial effects are expected to exert greater therapeutic efficacy compared with monotherapy. Poly(ADP-ribosyl)ation is reported to be involved in a variety of cellular processes, such as DNA repair, cell d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasukawa, Masaaki, Fujihara, Hisako, Fujimori, Hiroaki, Kawaguchi, Koji, Yamada, Hiroyuki, Nakayama, Ryoko, Yamamoto, Nanami, Kishi, Yuta, Hamada, Yoshiki, Masutani, Mitsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813136/
https://www.ncbi.nlm.nih.gov/pubmed/26927065
http://dx.doi.org/10.3390/ijms17030272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813136/
https://www.ncbi.nlm.nih.gov/pubmed/26927065
http://dx.doi.org/10.3390/ijms17030272

Ejemplares similares